|
View story
Acadia Begins Second Phase III Trial
http://www.rttnews.com/sp/breakingnews.asp?date=3/31/2008&it...
Submitted by
greenorganic
20 months, 18 hours agoAcadia Pharmaceuticals Inc. (ACAD) said that it has initiated its second Phase III trial designed to evaluate the safety and efficacy of pimavanserin as a treatment for Parkinson's disease psychosis or PDP.
#1 - By Marsha Sprague, 17 months, 4 days, 15 hours ago.
interested in obtaining information on PD
| |
We are your online resource for green living and organic lifestyle articles and stories. Live green, live organic, live sustainably.
copyright OrganicMOZ 2008